ABSTRACT
Importance: Although the effectiveness of intracameral antibiotics to prevent postoperative endophthalmitis is described, selective use of antibiotics combined with 1% povidone iodine disinfection might be equally effective and could lead to cost reduction and avoidance of unnecessary use of antibiotics. Objective: To compare the incidence of postoperative endophthalmitis when 1% povidone iodine disinfection is applied in combination with selective intracameral antibiotics with the incidence after routine use of intracameral antibiotics in combination with 5% povidone iodine. Design, Setting, and Participant: This was a retrospective cohort study using incidence data from the ongoing endophthalmitis register of the Rotterdam Eye Hospital, a specialized hospital providing both secondary and tertiary ophthalmological care, when intracameral antibiotics were used only during cataract procedures with occurrence of a posterior capsular tear in comparison with results from cohorts described in the literature where routine antibiotics were used. All patients who had cataract (phacoemulsification) surgery at the Rotterdam Eye Hospital between 1993 and 2022 were included. No cataract surgical procedures combined with other intraocular procedures were included. Exposure: Povidone iodine disinfection and intracameral antibiotics during cataract surgery either routinely or only in case of posterior capsular tears. Main Outcome and Measure: Postoperative endophthalmitis incidence. Results: Postoperative endophthalmitis incidence after 56â¯598 cataract (phacoemulsification) surgical procedures in the Rotterdam Eye Hospital between 2016 and 2022 was 0.000 (95% CI, 0.000-0.000). A PubMed literature search until September 2023 with respect to the incidence of postoperative endophthalmitis after routine antibiotic prophylaxis yielded 37 publications with an overall postoperative endophthalmitis incidence of 0.000 (95% CI, 0.000-0.000). Conclusions and Relevance: No difference was observed between the postoperative endophthalmitis incidence during the last 7 years in the Rotterdam Eye Hospital and the overall postoperative endophthalmitis incidence after routine intracameral antibiotics prophylaxis as described in the literature. Disinfection with 1% povidone iodine in combination with selective antibiotic prophylaxis may be equally effective as routine antibiotic use and 5% povidone iodine.
Subject(s)
Anterior Chamber , Anti-Bacterial Agents , Antibiotic Prophylaxis , Endophthalmitis , Eye Infections, Bacterial , Povidone-Iodine , Humans , Endophthalmitis/prevention & control , Endophthalmitis/epidemiology , Retrospective Studies , Incidence , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/administration & dosage , Povidone-Iodine/administration & dosage , Povidone-Iodine/therapeutic use , Aged , Male , Eye Infections, Bacterial/prevention & control , Eye Infections, Bacterial/epidemiology , Eye Infections, Bacterial/microbiology , Female , Anterior Chamber/drug effects , Postoperative Complications/prevention & control , Anti-Infective Agents, Local/therapeutic use , Anti-Infective Agents, Local/administration & dosage , Phacoemulsification/adverse effects , Aged, 80 and over , Cataract Extraction/adverse effects , Middle Aged , Netherlands/epidemiologySubject(s)
Anterior Chamber , Anti-Bacterial Agents , Cataract Extraction , Endophthalmitis , Humans , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Anterior Chamber/drug effects , Endophthalmitis/prevention & control , Eye Infections, Bacterial/prevention & control , Eye Infections, Bacterial/microbiologyABSTRACT
PURPOSE: This study compared the anti-pseudomonal effects between nephrite-impregnated contact lenses (CLs) and conventional and cosmetic CLs. METHODS: After inoculation with Pseudomonas aeruginosa (P.aeruginosa), we counted the number of bacteria on the CL surface and observed each surface using atomic force microscopy (AFM) and scanning electron microscopy (SEM). To estimate potential harm of nephrite-impregnated CLs, we conducted a safety test using a rabbit model, treated with all CL types. RESULTS: Both conventional and cosmetic CLs (n = 258 ± 2.9 × 104, 368 ± 2.2 × 104) showed significantly decreased number of attached bacteria when compared with those without nephrite impregnation (n = 134 ± 0.8 × 104, 238 ± 2.5 × 104, p < 0.0001, respectively). AFM and SEM revealed that P. aeruginosa was less attached to the nephrite-impregnated CLs than to the conventional and cosmetic CLs, although those with nephrite impregnation had rougher surface. In the safety test, there were no significant differences in the findings between four groups, and the clarity and stability of all corneas were preserved. CONCLUSIONS: Nephrite may be used as a next-generation substance to reduce infectious keratitis caused by P. aeruginosa when added to CLs.
Subject(s)
Microscopy, Electron, Scanning , Pseudomonas Infections , Pseudomonas aeruginosa , Rabbits , Animals , Pseudomonas aeruginosa/drug effects , Pseudomonas Infections/microbiology , Pseudomonas Infections/prevention & control , Microscopy, Atomic Force , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/prevention & control , Contact Lenses, Hydrophilic/microbiology , Disease Models, Animal , Contact Lens Solutions/pharmacology , Contact Lenses/microbiologyABSTRACT
PURPOSE: To demonstrate the noninferiority in antimicrobial effectiveness of thrice-repeated applications of 1% povidone-iodine (PI) compared with a single application of 5% PI on the ocular surface in vivo and to evaluate potential toxicity of PI to the corneal epithelium. SETTING: Department of Ophthalmology, Shaare Zedek Medical Center, Jerusalem, Israel. DESIGN: Prospective, randomized, double-blind study. METHODS: Patients randomly received either a single application of 5% PI or repeated irrigations of 1% PI on the ocular surface preoperatively. Bacterial colony counts were quantitatively analyzed by taking standardized conjunctival swabs before and after irrigation, and differences in bacterial colony counts were compared between the 2 groups. The presence of superficial punctate keratopathy was evaluated in all patients by the National Eye Institute grading system. RESULTS: The study comprised 102 eyes of 102 patients. Both 1% and 5% PI yielded a marked decrease in bacterial colonies compared with before application ( P < .001). The repeated application of 1% PI showed a significantly lower bacterial count compared with the single application of 5% PI ( P < .05) and resulted in significantly less damage to the corneal epithelium compared with a single 5% PI application ( P < .001). CONCLUSIONS: Preoperative repeated applications of 1% PI effectively eradicated ocular surface bacteria equal to that of 5% PI with a less deleterious effect on the corneal epithelium. Our findings suggest that 1% PI may be a promising alternative to 5% PI.
Subject(s)
Anti-Infective Agents, Local , Bacteria , Colony Count, Microbial , Conjunctiva , Povidone-Iodine , Humans , Prospective Studies , Double-Blind Method , Anti-Infective Agents, Local/toxicity , Female , Male , Middle Aged , Aged , Bacteria/drug effects , Bacteria/isolation & purification , Conjunctiva/microbiology , Conjunctiva/drug effects , Epithelium, Corneal/drug effects , Epithelium, Corneal/microbiology , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/prevention & control , Eye Infections, Bacterial/drug therapy , AdultABSTRACT
PURPOSE: The authors sought to determine if universal face mask guidelines implemented during the coronavirus disease 2019 pandemic significantly influenced the incidence of endophthalmitis following intravitreal injections (IVI). METHODS: This retrospective cohort study reviewed the electronic health records from a retina-only practice located in Michigan. This study evaluated patients receiving IVIs over two distinct time periods of April 2019 to March 2020 and April 2020 to March 2021, which comprised our unmasked and masked groups, respectively. The authors then calculated the incidence of endophthalmitis following IVI and evaluated the cases of post-injection endophthalmitis for both time periods. RESULTS: A total of 121,384 IVIs performed over the 2-year period of interest. Of these, 63,114 were unmasked and 58,270 were masked patient encounters. A total of 46 post-injection endophthalmitis cases were identified. Of these, 29 cases were from the unmasked period and 17 were from the masked period. This resulted in an incidence of endophthalmitis of 0.046% and 0.038% in the masked and unmasked groups, respectively. This difference did not rise to the level of statistical significance ( P = 0.1336). CONCLUSION: This study suggests that the incidence of post-injection endophthalmitis was not influenced by the implementation of ophthalmologist-patient face masking after IVI during the coronavirus disease 2019 pandemic.
Subject(s)
COVID-19 , Endophthalmitis , Intravitreal Injections , Masks , SARS-CoV-2 , Humans , Endophthalmitis/epidemiology , Endophthalmitis/prevention & control , Endophthalmitis/etiology , Intravitreal Injections/adverse effects , Retrospective Studies , COVID-19/epidemiology , COVID-19/prevention & control , Incidence , Male , Female , Aged , Middle Aged , Michigan/epidemiology , Angiogenesis Inhibitors/administration & dosage , Eye Infections, Bacterial/epidemiology , Eye Infections, Bacterial/prevention & control , Eye Infections, Bacterial/etiology , PandemicsABSTRACT
PURPOSE: This study aimed to evaluate the efficacy and safety of McCarey-Kaufman (MK) medium supplemented with colistin and amphotericin B in inhibiting the growth of multidrug-resistant Pseudomonas (P.) aeruginosa , using an ex vivo experimental model with human donor corneas. METHODS: Cadaveric human corneas deemed unsuitable for corneal transplantation were obtained, and MK media were supplemented with colistin and amphotericin B. Multidrug-resistant P. aeruginosa was cultured and used to infect the human donor corneas ex vivo . Infected corneas were placed in the MK media with additional antibiotics (colistin and amphotericin B) and the standard MK media, which served as the control arm for comparison. Corneal opacity due to infiltration and quantitative analysis of colony-forming units (CFUs) were assessed. The viability of the corneal endothelium was assessed using trypan blue staining. RESULTS: Corneas incubated in MK media supplemented with additional antibiotics showed less corneal opacification compared with those in standard MK media at both 48- and 96-hour (hr) time points. Quantitative analysis revealed a lower bacterial load and a significant reduction in CFU in the corneas incubated in MK media with additional antibiotics compared with the control group. At 48 hrs, there was 84% ( P value = 0.024) reduction in bacterial load, and at 96 hr, a 53% ( P value = 0.016) reduction was observed in comparison with those placed in standard MK media. The trypan blue staining tests revealed that the extent of endothelial cell loss in corneas incubated in supplemented MK media was comparable to the ones in standard MK media. CONCLUSION: The addition of colistin and amphotericin B to MK media demonstrated efficacy in inhibiting the growth of multidrug-resistant P. aeruginosa in an ex vivo cornea infection model. The supplemented media had no detrimental effect on the corneal endothelium. The findings suggest that supplementing the MK media with these broad-spectrum antimicrobial agents may help mitigate the risk of postoperative donor-related infection in the recipients by reducing and containing the load of microbial contamination in donor corneas.
Subject(s)
Amphotericin B , Anti-Bacterial Agents , Colistin , Eye Infections, Bacterial , Pseudomonas Infections , Pseudomonas aeruginosa , Tissue Donors , Colistin/pharmacology , Colistin/administration & dosage , Humans , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/prevention & control , Amphotericin B/pharmacology , Amphotericin B/administration & dosage , Pseudomonas Infections/drug therapy , Pseudomonas Infections/microbiology , Anti-Bacterial Agents/pharmacology , Culture Media , Drug Resistance, Multiple, Bacterial , Cadaver , Microbial Sensitivity Tests , Cornea/microbiologyABSTRACT
PURPOSE: To compare the rates and outcomes of endophthalmitis after intravitreal injections (IVIs) for patients pretreated with 5% povidone-iodine (PI) and 0.05% chlorhexidine (CHX). DESIGN: A retrospective, single-center, comparative cohort study. PARTICIPANTS: A total of 8686 patients were included in the study, and a total of 67 695 anti-VEGF injections were performed from January 1, 2019, to November 30, 2021. SETTING: A private retina practice of 13 retina specialists in Colorado. METHODS: Using electronic health records, patients with preinjection preparation with PI or CHX were compiled retrospectively. Use of prefilled versus nonprefilled syringes was also tabulated. Patients with postinjection endophthalmitis (PIE) were identified among the 2 groups. Postinjection endophthalmitis is defined as an inflammation of the eye from infectious agents after an IVI. Logarithm of the minimum angle of resolution (logMAR) visual acuity (VA) was determined at the time of causative anti-VEGF injection, endophthalmitis presentation, and 3-month follow-up. RESULTS: A total of 67 695 IVIs were administered by 13 retina specialists during the study period. A total of 13 of 32 802 (0.0396%; 1 in 2523 injections) cases of presumed endophthalmitis occurred in the PI group, and 9 of 34 893 (0.0258%; 1 in 3877 injections) cases in the CHX group (P = 0.395). For the PI group, there were 2 culture-positive endophthalmitis cases (0.0061%, 1 in 16 401), compared with 2 cases in the CHX group (0.00573%, 1 in 17 447) (P = 1.000). No significant difference was observed in the average logMAR VA of PI and CHX at causative injection (P = 0.3851), endophthalmitis encounter (P = 0.7718), and 3-month follow-up (P = 0.6152). A significant reduction in presumed endophthalmitis (P = 0.0445) and culture-positive cases (P = 0.0130) was present for prefilled IVI compared with nonprefilled injections. CONCLUSIONS: No significant difference in the rate of endophthalmitis or visual outcomes were found in the CHX group compared with the PI group. Prefilled syringes were associated with a significant reduction in endophthalmitis rate. Further multicenter studies are needed to validate the efficacy and safety of CHX compared with PI for IVI preparation. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Subject(s)
Angiogenesis Inhibitors , Anti-Infective Agents, Local , Chlorhexidine , Endophthalmitis , Eye Infections, Bacterial , Intravitreal Injections , Povidone-Iodine , Vascular Endothelial Growth Factor A , Visual Acuity , Humans , Endophthalmitis/diagnosis , Endophthalmitis/etiology , Endophthalmitis/prevention & control , Povidone-Iodine/administration & dosage , Retrospective Studies , Anti-Infective Agents, Local/administration & dosage , Angiogenesis Inhibitors/administration & dosage , Female , Male , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Chlorhexidine/administration & dosage , Aged , Eye Infections, Bacterial/diagnosis , Eye Infections, Bacterial/etiology , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/prevention & control , Eye Infections, Bacterial/drug therapy , Ranibizumab/administration & dosage , Follow-Up Studies , Middle Aged , Aqueous HumorSubject(s)
Cataract Extraction , Cataract , Endophthalmitis , Eye Infections, Bacterial , Humans , Cefuroxime/therapeutic use , Cost-Effectiveness Analysis , Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis , Endophthalmitis/etiology , Endophthalmitis/prevention & control , Cataract Extraction/adverse effects , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/prevention & control , Postoperative Complications/prevention & control , Anterior ChamberABSTRACT
Bacterial keratitis is a vision-threatening infection of the cornea that is typically treated with antibiotics. However, antibiotics sometimes fail to eradicate the infection and do not prevent or repair the damage caused directly by the bacteria or the host immune response to the infection. Our group previously demonstrated that treatment of Pseudomonas aeruginosa keratitis in rabbits with innovative cold atmospheric plasma (iCAP) resulted in reduced edema, ulcer formation, and bacterial load. In this study, we investigated the efficacy of iCAP treatment in methicillin-resistant Staphylococcus aureus (MRSA). New Zealand white rabbits were infected intrastromally with MRSA then treated with iCAP, moxifloxacin, vancomycin, or combination of iCAP with each antibiotic to assess the safety and efficacy of iCAP treatment compared to untreated controls and antibiotics. iCAP treatment significantly reduced bacterial loads and inflammation, improved anterior chamber clarity, and prevented corneal ulceration compared to untreated controls and antibiotic treatment. Safety assessments of grimace test scores and tear production showed that iCAP was not significantly different from either antibiotic treatment in terms of distress or tear production. Combination iCAP/antibiotic treatment did not appear to provide significant added benefit over iCAP alone. Our findings suggest that the addition of iCAP may be a viable tool in reducing damage to the cornea and anterior chamber of the eye following S. aureus keratitis.
Subject(s)
Corneal Ulcer , Eye Infections, Bacterial , Keratitis , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections , Rabbits , Animals , Corneal Ulcer/drug therapy , Corneal Ulcer/microbiology , Bacterial Load , Staphylococcus aureus , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Keratitis/drug therapy , Keratitis/prevention & control , Keratitis/microbiology , Anti-Bacterial Agents/therapeutic use , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/prevention & control , Eye Infections, Bacterial/microbiologyABSTRACT
Pseudomonas aeruginosa (P. aeruginosa) is one of the most prevalent pathogens of bacterial keratitis. Bacterial keratitis is a major cause of blindness worldwide. The rising incidence of multidrug resistance of P. aeruginosa precludes treatment with conventional antibiotics. Herein, we evaluated the protective efficiency and explored the possible underlying mechanism of an X-ray inactivated vaccine (XPa) using a murine P. aeruginosa keratitis model. Mice immunized with XPa exhibit reduced corneal bacterial loads and pathology scores. XPa vaccination induced corneal macrophage polarization toward M2, averting an excessive inflammatory reaction. Furthermore, histological observations indicated that XPa vaccination suppressed corneal fibroblast activation and prevented irreversible visual impairment. The potency of XPa against keratitis highlights its potential utility as an effective and promising vaccine candidate for P. aeruginosa.
Subject(s)
Eye Infections, Bacterial , Keratitis , Pseudomonas Infections , Animals , Mice , Pseudomonas aeruginosa , X-Rays , Vaccines, Inactivated/therapeutic use , Keratitis/prevention & control , Keratitis/drug therapy , Keratitis/microbiology , Cornea/microbiology , Cornea/pathology , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/pathology , Eye Infections, Bacterial/prevention & control , Pseudomonas Infections/prevention & control , Mice, Inbred C57BLABSTRACT
Moxifloxacin solution is frequently injected at the conclusion of cataract surgery for endophthalmitis prophylaxis. 2 different concentrations are most commonly available in the United States for intracameral (IC) use: 0.5% (5 mg/mL) and 0.1% (1 mg/mL). The recommended volume to be injected is different for the 2 concentrations, and incorrect dosing can increase the risk of toxic anterior segment syndrome or endophthalmitis. In addition, the U.S. Food and Drug Administration recently published an alert regarding potential adverse events associated with intraocular compounded moxifloxacin. This clinical advisory reviews the optimal dosing of IC moxifloxacin based on current evidence.
Subject(s)
Cataract Extraction , Endophthalmitis , Eye Infections, Bacterial , Humans , Moxifloxacin , Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis , Endophthalmitis/drug therapy , Eye Infections, Bacterial/prevention & control , Eye Infections, Bacterial/drug therapy , Anterior Chamber , Postoperative Complications/prevention & controlABSTRACT
PURPOSE: To investigate whether compulsory face masking in public life changes the incidence or pattern of post-injection endophthalmitis (PIE). PATIENTS AND METHODS: All injections of bevacizumab, ranibizumab, aflibercept, dexamethasone or triamcinolone between 01/01/2015 and 12/31/2021 at the University Eye Clinic of Tuebingen were included in this retrospective analysis. The injection procedure itself was unchanged since 2015 and included the use of a sterile drape covering the head up to the shoulders which prevents airflow toward the eye. Furthermore, all staff wore a face mask and gloves at all times. The two study periods were defined by the introduction of a compulsory face masking rule in public life (01/01/2015 until 04/27/2020 vs. 04/28/2020 until 12/31/2021). RESULTS: A total of 83,543 injections were performed in the tertiary eye clinic, associated with a total of 20 PIE (0.024%, 1/4177 injections). Of these, thirteen PIE were documented during the pre-pandemic period (0.021%, 1/4773 injections) and seven PIE during the pandemic period (0.033%, 1/3071 injections). No significant difference in PIE risk was observed (p = 0.49), and there was no case of oral flora associated PIE. CONCLUSION: Although some potential confounders (wearing time, skin flora) could not be considered, there was no clear signal that the introduction of compulsory face masking in public life did alter the risk for PIE in our patient population. Three and six months after PIE, no difference in visual acuity was detectable between the two study periods.
Subject(s)
Endophthalmitis , Eye Infections, Bacterial , Humans , Angiogenesis Inhibitors/therapeutic use , Intravitreal Injections , Retrospective Studies , Masks/adverse effects , Vascular Endothelial Growth Factor A , Eye Infections, Bacterial/epidemiology , Eye Infections, Bacterial/etiology , Eye Infections, Bacterial/prevention & control , Endophthalmitis/epidemiology , Endophthalmitis/etiology , Endophthalmitis/prevention & control , Ranibizumab , Bevacizumab , IncidenceABSTRACT
Pseudomonas aeruginosa infection is a severe acute suppurative ulcer that engulfs virtually the entire tissue in a short period and leads to devastating destruction. Antibiotic therapy is a common approach for the prophylaxis and treatment of P. aeruginosa infection. However, it is often associated with serious side effects, complications, and multidrug resistance. Therefore, it has been a long-standing challenge to explore safe and effective methods for controlling P. aeruginosa infection. Herein, tannin-coordinated nanozyme composite-based hybrid hydrogels (TCNH) are developed and characterized for the prophylactic treatment of P. aeruginosa and multidrug-resistant P. aeruginosa infections using mouse keratitis as the animal model. The TCNH eye drops are constructed by photoinitiated free radical polymerization of acetylated gelatin solution containing self-synthesized tannin-coordinated Co3O4/Ag nanozyme composite. The as-prepared TCNH displays good dispersibility, peroxidase-like activity and in vitro/in vivo biocompatibility. The nanozyme composite in TCNH seems to penetrate the interior of bacteria and exhibited significant broad-spectrum antibacterial activity owing to its intrinsic and nanozymic catalytic properties. Furthermore, TCNH eye drops can be successfully applied to treat P. aeruginosa and multidrug-resistant P. aeruginosa keratitis. The findings of this study reveal the potential of tannin-coordinated nanozyme composite-based hybrid hydrogel eye drops for treating infectious diseases.
Subject(s)
Eye Infections, Bacterial , Keratitis , Pseudomonas Infections , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Cobalt , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/prevention & control , Gelatin/pharmacology , Hydrogels , Keratitis/drug therapy , Keratitis/microbiology , Keratitis/prevention & control , Mice , Ophthalmic Solutions/pharmacology , Ophthalmic Solutions/therapeutic use , Oxides , Peroxidases , Pseudomonas Infections/drug therapy , Pseudomonas Infections/prevention & control , Pseudomonas aeruginosa , Tannins/pharmacology , Tannins/therapeutic useABSTRACT
Purpose: To compare different endophthalmitis prophylaxis methods adopted in cataract surgery (manual small-incision cataract surgery and phacoemulsification) between the years 2013 and 2021 in the community eye care section of a tertiary eye care hospital in South India and report their outcomes. Methods: All cataract surgeries performed from January 2013 to December 2021 (2,46,874 surgeries) at a single center were included in this retrospective study. The different endophthalmitis rates with each regimen were analyzed and evaluated. Results: 70,081 surgeries were performed from January 2013 to February 2015, where Tobramycin was added to Balanced Salt Solution (BSS) (Group A). From March 2015 to January 2017, 63,245 surgeries were performed when intracameral Moxifloxacin was given (Group B). From February 2017 to December 2021, 1,13,548 surgeries were performed were Amikacin was added to BSS (Group C). In total, 42 cases of postoperative endophthalmitis were reported during the study period (0.02%). There was no significant difference in the endophthalmitis rates between groups A and B (P = 0.4152); however, there was a significant decrease in endophthalmitis rates in group C when compared with group A (P = 0.04) and group B (P = 0.006). Conclusion: There was a significant reduction in the rates of endophthalmitis following the addition of amikacin in irrigating BSS. Nocardia was one of the predominant organisms isolated from these endophthalmitis patients. This is the first single-center study to report a comparative analysis of different endophthalmitis prophylactic measures in a community eye care set up with a high incidence of Nocardia endophthalmitis prevented with amikacin in BSS irrigating solution.
Subject(s)
Cataract Extraction , Cataract , Endophthalmitis , Eye Infections, Bacterial , Humans , Retrospective Studies , Antibiotic Prophylaxis/methods , Eye Infections, Bacterial/epidemiology , Eye Infections, Bacterial/prevention & control , Eye Infections, Bacterial/etiology , Amikacin , Anti-Bacterial Agents/therapeutic use , Endophthalmitis/epidemiology , Endophthalmitis/etiology , Endophthalmitis/prevention & control , Cataract Extraction/adverse effects , Postoperative Complications/epidemiology , Postoperative Complications/prevention & control , Postoperative Complications/drug therapy , Cataract/complicationsSubject(s)
Cataract Extraction , Cataract , Endophthalmitis , Eye Infections, Bacterial , Humans , Endophthalmitis/etiology , Endophthalmitis/prevention & control , Endophthalmitis/drug therapy , Cefuroxime , Cataract/drug therapy , Cataract Extraction/adverse effects , Postoperative Complications/prevention & control , Postoperative Complications/drug therapy , Anti-Bacterial Agents/therapeutic use , Retrospective Studies , Incidence , Eye Infections, Bacterial/etiology , Eye Infections, Bacterial/prevention & control , Eye Infections, Bacterial/drug therapyABSTRACT
PURPOSE: To examine the impact of physician face mask use on the rates and outcomes of postinjection endophthalmitis. METHODS: A multicenter retrospective, comparative cohort study comparing endophthalmitis rate and visual acuity of eyes that developed endophthalmitis after antivascular endothelial growth factor injections at Mayo Clinic Rochester (MCR) and at Mayo Clinic Health System sites depending on physician masking. RESULTS: A total of 164,824 injections were performed at MCR and Mayo Clinic Health System sites. Of these, 66,098 injections were in the no mask group and 98,726 injections were in the mask group. Overall, there were no differences in the rates of infectious endophthalmitis in the no mask versus mask cohorts (overall: no mask: 20 cases [0.0303%] vs. mask: 41 cases (0.0415%); P = 0.24; infectious: no mask: 12 cases [0.018%] versus mask: 13 cases [0.0132%]; P = 0.42). At MCR alone, there was a significant reduction in infectious endophthalmitis between the no mask versus mask groups (no mask: 9 cases [0.0297%] versus mask: 2 cases [0.003%]; P < 0.001). Only 2 cases of infectious endophthalmitis occurred at MCR after the face mask policy was implemented (1 in 30,000 injections). At presentation and at 6 months, the average visual acuity was similar for patients who developed endophthalmitis between the no mask versus mask groups. CONCLUSION: Physician face mask use did not affect the rate or outcome of postinjection endophthalmitis. However, there was a significant reduction at MCR after masking along with other quality improvement measures, including performance of injections in a dedicated procedure room and preparation of patients by nurses, that led to a low rate of endophthalmitis.
Subject(s)
Endophthalmitis , Eye Infections, Bacterial , Physicians , Humans , Intravitreal Injections , Ranibizumab/therapeutic use , Bevacizumab/therapeutic use , Eye Infections, Bacterial/epidemiology , Eye Infections, Bacterial/prevention & control , Eye Infections, Bacterial/drug therapy , Angiogenesis Inhibitors/therapeutic use , Retrospective Studies , Cohort Studies , Masks/adverse effects , Endothelial Growth Factors , Vascular Endothelial Growth Factor A , Endophthalmitis/epidemiology , Endophthalmitis/etiology , Endophthalmitis/prevention & controlABSTRACT
BACKGROUND: The use of antibiotics preoperatively is effective to decrease the incidence of ocular bacterial infections but may lead to high resistance rate, especially on patients with multi-risk clinical factors. This study systematically analyzed real-world data (RWD) of patients to reveal the association between clinical factors and conjunctival sac bacterial load and offer prophylaxis suggestions. METHODS: We retrieved RWD of patients using levofloxacin eye drops (5 mL: 24.4 mg, 4 times a day for 3 days) preoperatively. Retrieved data included information on the conjunctival sac bacterial culture, sex, presence of hypertension and diabetes mellitus (DM), and history of hospital-based surgeries. Data was analyzed using SPSS 24.0. RESULTS: RWD of 15,415 cases (patients) were retrieved. Among these patients, 5,866 (38.1%) were males and 9,549 (61.9%) females. 5,960 (38.7%) patients had a history of hypertension, and 3,493 (22.7%) patients had a history of DM. 7,555 (49.0%) patients had a history of hospital-based operations. There were 274 (1.8%) positive bacterial cultures. Male patients with hypertension and DM may be at increased risk of having positive bacterial cultures (P < 0.05). Staphylococcus epidermidis (n = 56, 20.4%), Kocuria rosea (n = 37, 13.5%), and Micrococcus luteus (n = 32, 11.7%) were the top 3 isolated strains. Most bacterial strains were resistant to various antibiotics except rifampin, and 82.5% (33 of 40 isolates) of Staphylococcus epidermidis isolates had multidrug antibiotic resistance. Numbers of culture-positive Staphylococcus epidermidis isolates in the male group and non-DM group were greater than those in the female and DM groups, respectively. Micrococcus luteus (n = 11, 8.8%) was found less frequently in non-hypertension group than in hypertension group. CONCLUSION: Sex (Male) and the presence of hypertension and DM are risk factors for greater conjunctival sac bacterial loads. We offer a prophylactic suggestion based on the combined use of levofloxacin and rifampin. However, this approach may aggravate risk of multidrug resistance.
Subject(s)
Anti-Bacterial Agents , Cataract Extraction , Eye Infections, Bacterial , Lacrimal Apparatus , Levofloxacin/administration & dosage , Anti-Bacterial Agents/therapeutic use , Conjunctiva/microbiology , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/epidemiology , Eye Infections, Bacterial/prevention & control , Female , Humans , Levofloxacin/therapeutic use , Male , Microbial Sensitivity Tests , Ophthalmic Solutions , Retrospective Studies , Rifampin , Staphylococcus epidermidisABSTRACT
PURPOSE: The study aims to investigate the role of the lipid mediator resolvin D1 (RvD1) in bacterial keratitis in a murine model. METHODS: The effect of RvD1 on Pseudomonas aeruginosa-stimulated human corneal epithelial cells (HCECs) and mouse macrophages and dendritic cells (DCs) was assessed. C57BL/6 mouse corneas were abraded and treated with RvD1 after stimulation with P. aeruginosa, following which cytokine production level in the cornea and drainage lymph nodes was compared with that in controls. Corneal opacity and thickness were assessed using anterior segment photographs, and optical coherence tomography and corneal infiltrates were analyzed using immunohistochemistry for neutrophils. RESULTS: RvD1 significantly inhibited pro-inflammatory cytokine production in HCECs, mouse macrophages, and DCs. Corneal opacity and corneal thickness were reduced, and the development of corneal infiltrates, specifically neutrophils, was also significantly inhibited by RvD1 in response to stimulation with P. aeruginosa. CONCLUSIONS: RvD1 inhibits P. aeruginosa-induced corneal inflammation. This finding supports a potential therapeutic approach for patients with bacterial keratitis.